ArticleThe pharmacogenomics journal2020

Genome-wide transcriptomics leads to the identification of deregulated genes after deferasirox therapy in low-risk MDS patients.

Jesús María Hernández Sánchez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.